Clinical characteristics, molecular profile and outcomes of myeloid sarcoma: a single institution experience over 13 years

References

• Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H. WHO classification of tumours of hematopoietic and lymphoid tissues, 4th ed. Lyon: IRAC; 2008. p. 140–141.
   Google Scholar
• Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114(5):937–951. doi: 10.1182/blood-2009-03-209262
   PubMed Web of Science ®Google Scholar
• Neiman RS, Barcos M, Berard C, et al. Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases. Cancer. 1981;48:1426–1437. [PubMed: 7023656]. doi: 10.1002/1097-0142(19810915)48:6<1426::AID-CNCR2820480626>3.0.CO;2-G
   PubMed Web of Science ®Google Scholar
• Muss HB, Moloney WC. Chloroma and other myeloblastic tumors. Blood. 1973;42:721–728. [PubMed: 4518064].
   PubMed Web of Science ®Google Scholar
• Menasce LP, Banerjee SS, Beckett E, et al. Extra-medullary myeloid tumour (granulocytic sarcoma) is often misdiagnosed: a study of 26 cases. Histopathology. 1999;34:391–398. [PubMed: 10231412]. doi: 10.1046/j.1365-2559.1999.00651.x
   PubMed Web of Science ®Google Scholar
• Pileri SA, Ascani S, Cox MC, et al. Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia. 2007;21:340–350. doi: 10.1038/sj.leu.2404491
   PubMed Web of Science ®Google Scholar
• Paydas S, Zorludemir S, Ergin M. Granulocytic sarcoma: 32 cases and review of the literature. Leuk Lymphoma. 2006;47(12):2527–2541. doi: 10.1080/10428190600967196
   PubMed Web of Science ®Google Scholar
• Al-Khateeb H, Badheeb A, Haddad H, et al. Myeloid sarcoma: clinicopathologic, cytogenetic, and outcome analysis of 21 adult patients. Leuk Res Treatment. 2011;2011:523168.
   PubMedGoogle Scholar
• Yamauchi K, Yasuda M. Comparison in treatments of non-leukemic granulocytic sarcoma: report of two cases and a review of 72 cases in the literature. Cancer. 2002;94(6):1739–1746. doi: 10.1002/cncr.10399
   PubMed Web of Science ®Google Scholar
• Tallman MS, Hakimian D, Shaw JM, et al. Granulocytic sarcoma is associated with the 8;21 translocation in acute myeloid leukemia. J Clin Oncol. 1993;11(4):690–697. doi: 10.1200/JCO.1993.11.4.690
   PubMed Web of Science ®Google Scholar
• Byrd JC, Weiss RB, Arthur DC, et al. Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): Results from cancer and leukemia group B 8461. J Clin Oncol. 1997;15:466–475. doi: 10.1200/JCO.1997.15.2.466
   PubMed Web of Science ®Google Scholar
• Tsimberidou AM, Kantarjian HM, Wen S, et al. Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemia. Cancer. 2008;113(6):1370–1378. doi: 10.1002/cncr.23691
   PubMed Web of Science ®Google Scholar
• Felice MS, Zubizarreta PA, Alfaro EM, et al. Good outcome of children with acute myeloid leukemia and t(8;21)(q22;q22), even when associated with granulocytic sarcoma: a report from a single institution in Argentina. Cancer. 2000;88:1939–1944. doi: 10.1002/(SICI)1097-0142(20000415)88:8<1939::AID-CNCR24>3.0.CO;2-Z
   PubMed Web of Science ®Google Scholar
• Alexiev BA, Wang A, Ning Y, et al. Myeloid sarcomas: a histologic, immunohistochemical, and cytogenetic study. Diagn Pathol. 2007;2(1):42. doi: 10.1186/1746-1596-2-42
   PubMed Web of Science ®Google Scholar
• Deeb G, Baer MR, Gaile DP, et al. Genomic profiling of myeloid sarcoma by array comparative genomic hybridization. Genes Chromosomes Cancer. 2005;44(4):373–383. doi: 10.1002/gcc.20239
   PubMed Web of Science ®Google Scholar
• Mirza MK, Sukhanova M, Stozel F, et al. Genomic aberrations in myeloid sarcoma without blood or bone marrow involvement: characterization of formalin-fixed paraffin-embedded samples by chromosomal microarrays. Leuk Res. 2014;38(9):1092–1096. doi: 10.1016/j.leukres.2014.05.004
   Web of Science ®Google Scholar
• Ansari-Lari MA, Yang CF, Tinawi-Aljundi R, et al. FLT3 mutations in myeloid sarcoma. Br J Haematol. 2004;126(6):785–91. doi: 10.1111/j.1365-2141.2004.05124.x
   PubMed Web of Science ®Google Scholar
• Falini B, Mecucci C, Tiacci E, et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med. 2005;352(3):254–266. doi: 10.1056/NEJMoa041974
   PubMed Web of Science ®Google Scholar
• Seifert RP, Bulkeley W, Zhang L, et al. A practical approach to diagnose soft tissue myeloid sarcoma preceding or coinciding with acute myeloid leukemia. Ann Diagn Pathol. 2014;18(4):253–260. doi: 10.1016/j.anndiagpath.2014.06.001
   PubMed Web of Science ®Google Scholar
• Lan TY, Lin DT, Tien HF, et al. Prognostic factors of treatment outcomes in patients with granulocytic sarcoma. Acta Haematol. 2009;122(4):238–246. doi: 10.1159/000253592
   PubMed Web of Science ®Google Scholar
• Suh YK, Shin HJ. Fine-needle aspiration biopsy of granulocytic sarcoma: a clinicopathologic study of 27 cases. Cancer. 2000;90(6):364–372. doi: 10.1002/1097-0142(20001225)90:6<364::AID-CNCR7>3.0.CO;2-1
   PubMed Web of Science ®Google Scholar
• Guermazi A, Feger C, Rousselot P, et al. Granulocytic sarcoma (chloroma): imaging findings in adults and children. AJR Am J Roentgenol. 2002;178(2):319–325. doi: 10.2214/ajr.178.2.1780319
   PubMed Web of Science ®Google Scholar
• Shinagare AB, Krajewshi KM, Hornick JL, et al. MRI for evaluation of myeloid sarcoma in adults: a single institution 10 year experience. AJR Am J Roentgenol. 2012;199(6):1193–1198. doi: 10.2214/AJR.12.9057
   PubMed Web of Science ®Google Scholar
• Ooci GC, Chim CS, Khong PL, et al. Radiologic manifestations of granulocytic sarcoma in adult leukemia. AJR Am J Roentgenol. 2001;176(6):1427–1431. doi: 10.2214/ajr.176.6.1761427
   PubMed Web of Science ®Google Scholar
• Udea K, Ichikawa M, Takahashi M, et al. FDG-PET is effective in the detection of granulocytic sarcoma in patients with myeloid malignancy. Leuk Res. 2010;34(9):1239–1241. doi: 10.1016/j.leukres.2010.04.017
   PubMed Web of Science ®Google Scholar
• Stolzel F, Christoph R, Radke J, et al. 18F-FDG-PET/CT for detection of extramedullary acute myeloid leukemia. Haematologica. 2011;96(10):1552–1556. doi: 10.3324/haematol.2011.045047
   PubMed Web of Science ®Google Scholar
• Faaij CM, Willemze AJ, Revesz T, et al. Chemokine/chemokine receptor interactions in extramedullary leukaemia of the skin in childhood AML: differential roles of CCR2, CCR5, CXCR4 and CXCR7. Pediatr Blood Cancer. 2010;55(2):344–348. doi: 10.1002/pbc.22500
   PubMed Web of Science ®Google Scholar
• Stefanidakis M, Karjalainen K, Jaalouk DE, et al. Roel of leukemia cell invadosome in extramedullay infiltration. Blood. 2009;114(14):3008–3017. doi: 10.1182/blood-2008-04-148643
   PubMed Web of Science ®Google Scholar
• Wang C, Chen Z, Li Z, et al. The essential roles of matrix metalloproteinase-2, membrane type 1 metalloproteinase and tissue inhibitor of metalloproteinase-2 in the invasive capacity of acute monocytic leukemia SHI-1 cells. Leuk Res. 2010;34(8):1083–1090. doi: 10.1016/j.leukres.2010.01.016
   PubMed Web of Science ®Google Scholar
• Cunningham I. Extramedullary sites of leukemia relapse after transplant. Leuk Lymhoma. 2006;47(9):1754–1767. doi: 10.1080/10428190600632857
   PubMed Web of Science ®Google Scholar
• Avni BR, Rund D, Levin M, et al. Clinical implications of acute myeloid leukemia presenting as granulocyticsarcoma. Hematol Oncol. 2012;30(1):34–40. doi: 10.1002/hon.994
   PubMed Web of Science ®Google Scholar